Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Crit Rev Biotechnol. 2017 Apr 24;38(1):47–67. doi: 10.1080/07388551.2017.1312267

Figure 6.

Figure 6

Schematic for intestinal drug transport using WGA-conjugated lipid NPs targeted to intestinal mucosal cells: (a,c) fluid phase endocytosis, (b) binding of WGA to glycoproteins followed by receptor-mediated endocytosis, (d) transcellular transport, (e) endocytosis might be blocked by absence of receptors or unsuitable conditions